AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 176 filers reported holding AXSOME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $786,542 | -9.5% | 11,254 | -0.1% | 0.71% | +100.0% |
| Q4 2022 | $868,792 | +48.8% | 11,264 | -26.1% | 0.35% | +72.2% |
| Q2 2022 | $584,000 | -85.9% | 15,246 | -84.8% | 0.20% | -81.2% |
| Q1 2022 | $4,151,000 | +97.5% | 100,299 | +80.3% | 1.09% | +115.6% |
| Q4 2021 | $2,102,000 | +22.5% | 55,629 | +6.9% | 0.51% | +29.7% |
| Q3 2021 | $1,716,000 | +135.7% | 52,048 | +320.9% | 0.39% | +18.5% |
| Q1 2020 | $728,000 | -36.9% | 12,367 | +10.9% | 0.33% | -9.1% |
| Q4 2019 | $1,153,000 | +55.0% | 11,151 | -78.7% | 0.36% | +23.5% |
| Q1 2019 | $744,000 | +26.1% | 52,268 | -75.0% | 0.29% | -5.8% |
| Q4 2018 | $590,000 | +79.9% | 209,195 | +119.8% | 0.31% | +113.7% |
| Q3 2018 | $328,000 | – | 95,185 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
| Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
| VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
| Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
| SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
| Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
| BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
| RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
| PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |